Bruker Corporation Announces Powerful New Mass Spectrometry Systems And Solutions For Life-Science Research, Clinical Research, Biopharma And Applied Markets
6/16/2014 10:35:08 AM
BALTIMORE--(BUSINESS WIRE)--At the 62nd ASMS Conference on Mass Spectrometry and Allied Topics today, Bruker Corporation (NASDAQ:BRKR) today announced mass spectrometry-based product introductions for life-science research and proteomics, for clinical research, for pharma/biopharma/CRO customers, as well as for applied and industrial markets. The new systems and solutions are designed to deliver confident analyses with significantly enhanced performance, productivity and versatility.
Help employers find you! Check out all the jobs and post your resume.
comments powered by